Get support Donate

Minoryx receives a EUR 26.9m grant within the framework of the European IPCEI Med4Cure project for the continued development of leriglitazone in lethal orphan CNS diseases

Adrenoleukodystrophy (ALD)

https://www.minoryx.com/media/minoryx_receives_a_eur_26.9m_grant_within_the_framework_of_the_european_ipcei_med4cure_project